Peter End
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cellular transport and secretion 3
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- George Panayotou (8 shared papers)Monique Aumailley (1 shared paper)Rupert Timpl (1 shared paper)Jürgen ENGEL (1 shared paper)Michael Derek Waterfield (6 shared papers)Andreas Benesic (1 shared paper)Raúl Jesús Andrade Bellido (1 shared paper)Guruprasad Padur Aithal (1 shared paper)
- Journals
- Molecular and Cellular Biology (3 papers)Clinical and Translational Science (2 papers)Drug Metabolism and Disposition (2 papers)Chemical Research in Toxicology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Peter End
22 papers receiving 2.0k citations
Peter End's Hit Papers
Peers
Comparison fields: 5 of 115
- Immunology and Allergy 262
- Pharmacology 322
- Nephrology 189
- Cell Biology 264
- Hepatology 95
Countries citing papers authored by Peter End
This map shows the geographic impact of Peter End's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter End with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter End more than expected).
Fields of papers citing papers by Peter End
This network shows the impact of papers produced by Peter End. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter End. The network helps show where Peter End may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter End, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug-induced liver injury: recent advances in diagnosis and risk assessment Hit paper breakdown → | 2017 | 391 |
| 2 | 1989 | 318 | |
| 3 | 2010 | 295 | |
| 4 | 1992 | 182 | |
| 5 | 2013 | 145 | |
| 6 | 1993 | 139 | |
| 7 | 2007 | 109 | |
| 8 | 1992 | 84 | |
| 9 | 2021 | 84 | |
| 10 | 2021 | 71 | |
| 11 | 1993 | 48 | |
| 12 | 1993 | 31 | |
| 13 | 1993 | 28 | |
| 14 | 2020 | 27 | |
| 15 | 2017 | 19 | |
| 16 | 2015 | 18 | |
| 17 | 1993 | 18 | |
| 18 | 1991 | 15 | |
| 19 | 2021 | 10 | |
| 20 | 2022 | 9 |
About Peter End
Peter End is a scholar working on Cell Biology, Pharmacology, Hematology, Immunology and Allergy and Immunology, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cell Adhesion Molecules Research (3 papers), Cellular transport and secretion (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Complement system in diseases (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Immunology and Allergy (262 citations), Pharmacology (322 citations), Nephrology (189 citations), Cell Biology (264 citations) and Hepatology (95 citations). Peter End has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include George Panayotou, Monique Aumailley, Rupert Timpl, Jürgen ENGEL, Michael Derek Waterfield, Andreas Benesic, Raúl Jesús Andrade Bellido, Guruprasad Padur Aithal, Michael K. Merz and Gerd Achim Kullak-Ublick. Their work appears in journals such as Molecular and Cellular Biology, Clinical and Translational Science, Drug Metabolism and Disposition, Chemical Research in Toxicology and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.